The following is a continuation of all our recent MindMed coverage.

Last week, we published the first conversation with Jake Freeman.

Before that, it all began with a two-part interview with Dr. Scott Freeman in August.

Jake Freeman’s Letter to MindMed CEO, Robert Barrow

In case you’re joining us late, Jake Freeman issued a letter directly to Robert Barrow back on October 3rd. If you scroll down to the last paragraph, Jake sets the table for a potential debate on our platform. We’re still waiting for that to happen.

This MindMed ($MNMD) story does not seem to be fizzing out anytime soon. We will continue to be at the center of all of the drama.

Follow on the Psychedelic Invest YouTube Channel

As always, please like and subscribe to the Psychedelic Invest YouTube channel.